Free Trial
Your $100 Credit Is Waiting! Get MarketBeat All Access Today
Lock In $149
Claim MarketBeat All Access Sale Promotion

ACADIA Pharmaceuticals (ACAD) Insider Trading & Ownership

ACADIA Pharmaceuticals logo
$20.95 +0.47 (+2.29%)
Closing price 04:00 PM Eastern
Extended Trading
$21.00 +0.05 (+0.26%)
As of 07:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ACADIA Pharmaceuticals (NASDAQ:ACAD) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
26.20%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
6
Amount Of
Insider Selling
(Last 12 Months)
$2.35M
Get ACAD Insider Trade Alerts

Want to know when executives and insiders are buying or selling ACADIA Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ACAD Insider Buying and Selling by Quarter

ACADIA Pharmaceuticals Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/4/2026Sell1,332$21.79$29,024.28  
5/4/2026Sell3,506$21.79$76,395.74  
4/7/2026Sell1,030$22.20$22,866.00  
4/7/2026Sell2,709$22.20$60,139.80  
2/9/2026Sell6,950$23.38$162,491.00  
11/18/2025Sell4,084$23.69$96,749.96  
11/18/2025Sell10,262$23.69$243,106.78  
11/10/2025
James M Daly
Director
Sell30,000$22.37$671,100.00  
9/15/2025Sell3,498$23.65$82,727.70  
9/2/2025Sell1,600$25.98$41,568.00  
Are we ignoring the same signal Wall Street ignored in 1929? (Ad)

In 1929, Irving Weiss spotted a systemic crisis hiding beneath record highs and shorted the market - turning $500 into a fortune while the average stock lost 90% of its value. His son Martin later digitized those same formulas into Weiss Ratings, a system now tracking 22,000 stocks with 1.2 billion daily calculations. That system called the bank failures of the 1980s, the dot-com bust, 2008, and the 2020 crash. Right now it is flashing Code Red - issuing Must-Sell warnings on 10 widely held US stocks and upgrading 3 under-the-radar names to an urgent Buy. Access the full briefing at 79% off during the Memorial Day Savings Event.tc pixel

Watch the market briefing and claim your 79% Memorial Day discount now
8/18/2025Sell22,000$25.18$553,960.00  
6/4/2025
Laura Brege
Laura Brege
Director
Sell14,446$21.78$314,633.88  
(Data available from 1/1/2013 forward)

ACAD Insider Trading Activity - Frequently Asked Questions

The list of insiders at ACADIA Pharmaceuticals includes Austin D Kim, Brendan Teehan, Bros. Advisors Lp Baker, Elizabeth A Garofalo, James Kihara, James M Daly, Jennifer J Rhodes, Laura Brege, Mark C Schneyer, and Stephen Davis. Learn more on insiders at ACAD.

26.20% of ACADIA Pharmaceuticals stock is owned by insiders. Learn more on ACAD's insider holdings.

The following insiders have sold ACAD shares in the last 24 months: Brendan Teehan ($319,310.01), Elizabeth A Garofalo ($131,241.37), James Kihara ($369,867.28), James M Daly ($671,100.00), Jennifer J Rhodes ($162,491.00), Laura Brege ($314,633.88), Mark C Schneyer ($1,562,622.29), and Stephen Davis ($485,094.16).

Insiders have sold a total of 203,061 ACADIA Pharmaceuticals shares in the last 24 months for a total of $4,016,359.99 sold.



This page (NASDAQ:ACAD) was last updated on 5/20/2026 by MarketBeat.com Staff.
From Our Partners